The contribution of B cells to renal interstitial inflammation

American Journal of Pathology

Volumn 170, Issue 2, 2007, Pages 457-468

  Heller, Florian ^a   Lindenmeyer, Maja T ^a   Cohen, Clemens D ^a   Brandt, Ulrike ^a   Draganovici, Dan ^a   Fischereder, Michael ^c   Kretzler, Matthias ^a   Anders, Hans Joachim ^a   Sitter, Thomas ^a   Mosberger, Isabella ^b   Kerjaschki, Dontscho ^b   Regele, Heinz ^b   Schlöndorff, Detlef ^a   Segerer, Stephan ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c Klinikum der Universität München ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD3 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; MESSENGER RNA; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; BLR1 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; CXCL13 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL MATURATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FIBROSIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE; ACUTE DISEASE; ADOLESCENT; CHILD; CHRONIC DISEASE; IMMUNOLOGY; LYMPH VESSEL; MIDDLE AGED; PATHOLOGY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIGENS, CD; B-LYMPHOCYTES; CHEMOKINES, CXC; CHILD; CHRONIC DISEASE; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 33947539744     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060554     Document Type: Article

References (50)

1. Strutz F, Neilson EG: New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol 2003, 24:459-476
2. Müller GA, Markovic-Lipkovski J, Frank J, Rodemann HP: The role of interstitial cells in the progression of renal diseases. J Am Soc Nephrol 1992, 2:S198-S205
3. Alexopoulos E, Seron D, Hartley RB, Cameron JS: Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990, 37:100-109
4. Segerer S, Mack M, Regele H, Kerjaschki D, Schlondorff D: Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int 1999, 56:52-64
5. Segerer S, Banas B, Wornle M, Schmid H, Cohen CD, Kretzler M, Mack M, Kiss E, Nelson PJ, Schlondorff D, Grone HJ: CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 2004, 164:635-649
6. Angeli V, Ginhoux F, Llodra J, Quemeneur L, Frenette PS, Skobe M, Jessberger R, Merad M, Randolph GJ: B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006, 24:203-215
7. Martin F, Chan AC: B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 2006, 24:467-496
8. Edwards JC, Cambridge G: B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 2006, 6:394-403
9. Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, Soleiman A, Birner P, Krieger S, Hovorka A, Silberhumer G, Laakkonen P, Petrova T, Langer B, Raab I: Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004, 15:603-612
10. Aloisi F, Pujol-Borrell R: Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006, 6:205-217
11. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM: T cell activation in rheumatoid synovium is B cell dependent. J Immunol 2001, 167:4710-4718
12. Segerer S, Nelson PJ: Chemokines in renal diseases. Sci World J 2005, 5:835-844
13. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000, 11:152-176
14. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA: International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000, 52:145-176
15. Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M: A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996, 87:1037-1047
16. Müller G, Lipp M: Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr Opin Immunol 2003, 15:217-224
17. Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, Lipsky PE, Yoshikawa H, Ochi T: Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol 2001, 166:650-655
18. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM, Goronzy JJ, Weyand CM: Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001, 167:1072-1080
19. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987, 31:964-972
20. D'Agati VD, Appel GB, Estes D, Knowles II DM, Pirani CL: Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. Kidney Int 1986, 30:573-581
21. Husby G, Tung KS, Williams Jr RC: Characterization of renal tissue lymphocytes in patients with interstitial nephritis. Am J Med 1981, 70:31-38
22. Boucher A, Droz D, Adafer E, Laure-Helene N: Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 1986, 29:1043-1049
23. Cohen CD, Calvaresi N, Armelloni S, Schmid H, Henger A, Ott U, Rastaldi MP, Kretzler M: CD20-positive infiltrates in human membranous glomerulonephritis. J Nephrol 2005, 18:328-333
24. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra Jr O: Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003, 349:125-138
25. Cohen CD, Frach K, Schlondorff D, Kretzler M: Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 2002, 61:133-140
26. Segerer S, Bohmig GA, Exner M, Kerjaschki D, Regele H, Schlondorff D: Role of CXCR3 in cellular but not humoral renal allograft rejection. Transpl Int 2005, 18:676-680
27. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M: Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005, 166:913-921
28. Ordóñez NG: D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 2005, 36:372-380
29. Steinmetz OM, Panzer U, Kneissler U, Harendza S, Lipp M, Helmchen U, Stahl RA: BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 2005, 67:1616-1621
30. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M, Forster R: Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000, 192:1545-1552
31. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, Bartel G, Krober SM, Greinix H, Rosenmaier A, Karlhofer F, Wick N, Mazal PR: Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006, 12:230-234
32. Haas M: Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997, 29:829-842
33. McGinnes K, Letarte M, Paige CJ: B-lineage colonies from normal, human bone marrow are initiated by B cells and their progenitors. Blood 1991, 77:961-970
34. Pescovitz MD: Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant 2006, 6:859-866
35. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschenes G, Ronco PM: Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002, 346:2053-2060
36. Anolik JH, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, Kelly J, Milner EC, Fisher RI, Sanz I: B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clin Immunol (in press)
37. Müller G, Hopken UE, Lipp M: The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 2003, 195:117-135
38. Ishikawa S, Sato T, Abe M, Nagai S, Onai N, Yoneyama H, Zhang Y, Suzuki T, Hashimoto S, Shirai T, Lipp M, Matsushima K: Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med 2001, 193:1393-1402
39. Drayton DL, Liao S, Mounzer RH, Ruddle NH: Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006, 7:344-353
40. Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C: Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum 2005, 52:1773-1784
41. Marchal-Sommé J, Uzunhan Y, Marchand-Adam S, Valeyre D, Soumelis V, Crestani B, Soler P: Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 2006, 176:5735-5739
42. Armengol MP, Juan M, Lucas-Martin A, Fernandez-Figueras MT, Jaraquemada D, Gallart T, Pujol-Borrell R: Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am J Pathol 2001, 159:861-873
43. Novobrantseva TI, Majeau GR, Amatucci A, Kogan S, Brenner I, Casola S, Shlomchik MJ, Koteliansky V, Hochman PS, Ibraghimov A: Attenuated liver fibrosis in the absence of B cells. J Clin Invest 2005, 115:3072-3082
44. Matsui K, Nagy-Bojarsky K, Laakkonen P, Krieger S, Mechtler K, Uchida S, Geleff S, Kang DH, Johnson RJ, Kerjaschki D: Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase P and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 2003, 14:1981-1989
45. Achen MG, Mann GB, Stacker SA: Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 2006, 94:1355-1360
46. Alitalo K, Tammela T, Petrova TV: Lymphangiogenesis in development and human disease. Nature 2005, 438:946-953
47. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG: A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000, 406:309-314
48. Ghijsels E, Lerut E, Vanrenterghem Y, Kuypers D: Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure. Am J Kidney Dis 2004, 43:e34-e38
49. Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M, Perna A, Filippi C, Remuzzi G: Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol 2003, 14:1851-1857
50. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P: Rituximab for idiopathic membranous nephropathy. Lancet 2002, 360:923-924